SAN.PA : Summary for SANOFI - Yahoo Finance

U.S. Markets closed

Sanofi (SAN.PA)

Paris - Paris Delayed Price. Currency in EUR
Add to watchlist
75.62-0.15 (-0.20%)
At close: 5:35PM CET
People also watch
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Previous Close75.77
Bid71.12 x 1000
Ask71.74 x 44000
Day's Range75.20 - 76.43
52 Week Range62.50 - 79.07
Avg. Volume2,930,280
Market Cap94.94B
PE Ratio (TTM)23.20
Earnings DateN/A
Dividend & Yield3.35 (4.12%)
Ex-Dividend DateN/A
1y Target EstN/A
  • Reuters22 hours ago

    Pharma CEOs in Davos put brave face on Trump presidency

    Leaders of the global pharmaceutical industry, blasted by incoming U.S. President Donald Trump for "getting away with murder" on drug prices, are putting a brave face on the challenges in their biggest market.

  • Reuters23 hours ago

    Sanofi's M&A misses frustrate some investors in drugmaker

    PARIS/DAVOS, Switzerland (Reuters) - For the last year, Sanofi's chief executive has made clear his quest for deals to help revive the fortunes of France's biggest drugmaker. Olivier Brandicourt's failure to land two big biotech acquisitions he was chasing has led to growing impatience among some investors. In an interview at the World Economic Forum in the Swiss resort of Davos this week Brandicourt defended his track record, citing an unwillingness to overpay for pricey assets and a paucity of good opportunities.

  • The Wall Street Journalyesterday

    [$$] Rival to EpiPen Allergy Treatment to Return to Market

    The maker of an EpiPen rival said its emergency allergy treatment would return to the market on Feb. 14, adding more competition to the market for the costly products.